查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1609588

臨床試驗影像市場規模、佔有率、趨勢分析報告：按模式、按治療領域、按服務、按最終用途、按地區、按細分市場、預測，2025-2030 年

Clinical Trial Imaging Market Size, Share & Trends Analysis Report By Modality (Computed Tomography Scan, Magnetic Resonance Imaging), By Therapeutic Area, By Services, By End Use, Region, And Segment Forecasts, 2025 - 2030
出版日期: | 出版商: Grand View Research | 英文 200 Pages | 商品交期: 2-10個工作天內

價格

臨床試驗影像市場成長與趨勢：

Grand View Research, Inc.最新報告顯示，預計2030年全球臨床試驗影像市場規模將達到19.1億美元，2025年至2030年複合年成長率為7.8%。

用於發現治療慢性病的新藥和治療方法的研發支出不斷增加正在推動產業成長。從體內測試獲得的圖像用於確定藥物活性。臨床試驗影像可提供快速、詳細且準確的篩檢。在臨床試驗的各個階段，對臨床試驗影像診斷的需求正在迅速增加。醫療圖像在臨床試驗中用作主要、定量和替代生物標記。

臨床試驗設計包括患者群體選擇、基於生物標記的分層、各種治療分配方法、高效可靠的終點選擇和替代終點檢驗以及樣本大小計算、試驗模擬、適應性試驗設置、統計分析、中期分析和分析。

市場上的公司提供分析測試服務、藥物動力學、解釋和動態服務，以加強臨床開發。 IXICO 提供加速神經科學臨床試驗的先進技術。該公司的成像生物標記有助於衡量神經成像治療方法的安全性和有效性。成像生物標記對於放射學解釋很有用。這使得能夠解釋中樞神經系統 MRI 掃描，並增強對藥物安全性和受試者合格持續監測的評估。

臨床試驗成像市場報告亮點

  • 解讀與分析服務業在2024年佔據最大市場佔有率，為30.95%，預計2025年至2030年複合年成長率為8.4%，對於確保臨床研究中影像資料的準確性和可靠性具有重要意義。的角色
  • 2024年，生技和製藥公司板塊佔最大佔有率，達28.7%。導致這一領域佔據主導地位的一個因素是需要開發新的藥物和治療方法來治療慢性疾病。
  • 2024年，腫瘤領域佔比最大，為23.63%。癌症患者的高盛行率以及對治療各種類型癌症的創新治療方法的持續需求預計將推動市場成長。
  • 委外研發機構(CRO) 產業預計在預測期內將以 8.5% 的複合年成長率大幅成長，因為它在新藥和慢性病治療方法的開發中發揮著至關重要的作用。
  • 由於老年人口不斷成長、慢性病以及對治療方案的需求不斷增加，北美在 2024 年佔據市場主導地位，銷售額佔有率為 47.93%。

目錄

第1章調查方法與範圍

第 2 章執行摘要

第3章臨床試驗影像市場變數、趨勢與範圍

  • 市場體系展望
    • 母市場展望
    • 相關/附隨市場展望
  • 市場動態
    • 市場促進因素分析
    • 市場限制因素分析
  • 臨床試驗影像市場分析工具
    • 產業分析-波特五力分析
    • PESTEL分析

第 4 章 臨床試驗影像市場：按模式估計與趨勢分析

  • 細分儀表板
  • 臨床試驗影像市場：模態變異分析
  • 按模式分類的臨床試驗影像市場前景
  • 2018-2030年市場規模、預測及趨勢分析
  • 電腦斷層掃描
  • 磁振造影
  • X光
  • 超音波
  • 光學同調斷層掃描(OCT)
  • 其他方式

第5章臨床試驗影像市場：按治療領域估計和趨勢分析

  • 細分儀表板
  • 臨床試驗影像市場：治療區域變異分析
  • 臨床試驗影像市場治療領域展望
  • 2018-2030年市場規模、預測及趨勢分析
  • 神經血管疾病
  • 心血管疾病
  • 整形外科和 MSK 疾病
  • 腫瘤學
  • 眼科
  • 腎臟病學
  • 其他治療領域

第6章 臨床試驗影像市場：按服務分類的估計和趨勢分析

  • 細分儀表板
  • 臨床試驗影像市場：服務變化分析
  • 臨床試驗影像市場服務展望
  • 2018-2030年市場規模、預測及趨勢分析
  • 臨床試驗設計與諮詢服務
  • 閱讀與分析服務
  • 營運影像服務
  • 系統和技術支援服務
  • 計劃和資料管理

第7章 臨床試驗影像市場：最終用途的估計與趨勢分析

  • 細分儀表板
  • 臨床試驗影像市場：最終用途變異分析
  • 按最終用途分類的臨床試驗成像市場前景
  • 2018-2030年市場規模、預測及趨勢分析
  • 生物技術和製藥公司
  • 醫療設備製造商
  • 學術和政府研究機構
  • 受託研究機構（CRO）
  • 其他最終用戶

第8章 臨床試驗影像市場：區域估計與趨勢分析

  • 2024 年及 2030 年區域市場佔有率分析
  • 區域市場儀表板
  • 全球區域市場簡介
  • 2018-2030年市場規模、預測趨勢分析：
  • 北美洲
    • 美國
    • 加拿大
    • 墨西哥
  • 歐洲
    • 英國
    • 德國
    • 法國
    • 義大利
    • 西班牙
    • 挪威
    • 瑞典
    • 丹麥
  • 亞太地區
    • 日本
    • 中國
    • 印度
    • 澳洲
    • 韓國
    • 泰國
  • 拉丁美洲
    • 巴西
    • 阿根廷
  • 中東/非洲
    • 南非
    • 沙烏地阿拉伯
    • 阿拉伯聯合大公國
    • 科威特

第9章 競爭格局

  • 主要市場參與企業的最新趨勢和影響分析
  • 供應商情況
    • 主要經銷商及通路夥伴名單
    • 主要客戶
    • 2024年主要企業市場佔有率分析
    • IXICO plc
    • Navitas Life Sciences
    • Resonance Health
    • ProScan Imaging
    • Radiant Sage LLC
    • Medpace
    • Biomedical Systems Corp.
    • Cardiovascular Imaging Technologies
    • Intrinsic Imaging
    • BioTelemetry
Product Code: GVR-2-68038-628-8

Clinical Trial Imaging Market Growth & Trends:

The global clinical trial imaging market size is expected to reach USD 1.91 billion by 2030, registering a CAGR of 7.8% from 2025 to 2030, according to a new report by Grand View Research, Inc. Increasing research and development spending to discover new drugs and therapies to treat chronic diseases is propelling the industry growth. Images obtained from the internal examination of the body are used to determine drug activity. Clinical trial imaging provides rapid, detailed, and accurate screening. The need for clinical trial imaging is rapidly increasing in all phases of trials. Medical imaging in clinical trials is used as a primary, quantitative, and surrogate biomarker.

The clinical trial design includes selecting patient population, stratification based on biomarkers, different methods for allocation treatments, choosing efficient and reliable endpoints and validation of surrogate endpoints, calculating sample size, trial simulations, adaptive trial set-up, statistical and interim analysis, and assisting clients to deal with regulatory authorities such as EMA and FDA to discuss study design or defend study results.

Market players provide analytical testing services, pharmacokinetic, reading, and pharmacodynamics services for enhanced clinical development. IXICO offers advanced technologies for catalyzing clinical trials in neuroscience. Imaging biomarkers by the company help in measuring the safety and effectiveness of therapies used for neuro-imaging. Imaging biomarkers are effective in radiological reads. This provides the reading of MRI scans for central neuro to enhance the assessment of ongoing monitoring of drug safety and subject eligibility

Clinical Trial Imaging Market Report Highlights:

  • The reading and analytical services segment held the largest market share at 30.95% in 2024 and is expected to grow at a CAGR of 8.4% from 2025 to 2030, highlighting its critical role in ensuring the accuracy and reliability of imaging data in clinical research.
  • The biotechnology and pharmaceutical companies segment accounted for the largest share of 28.7% in 2024. The factor attributing to the dominance of this segment is the need to develop new drugs and therapies to cure chronic diseases.
  • Oncology segment held the largest market share of 23.63% in 2024. High prevalence of cancer cases and the constant need for new and innovative therapies to treat various types of cancer are expected to fuel the market growth.
  • The contract research organizations (CROs) segment is expected to grow significantly with a CAGR of 8.5% over the forecast period, owing to its essential role in developing new drugs and therapies for chronic diseases.
  • North America dominated the market with a revenue share of 47.93% in 2024 due to the increasing geriatric population, along with chronic diseases and growing demand for treatment options.

Table of Contents

Chapter 1. Methodology and Scope

  • 1.1. Market Segmentation and Scope
  • 1.2. Segment Definitions
    • 1.2.1. Modality
    • 1.2.2. Therapeutic Area
    • 1.2.3. Services
    • 1.2.4. End Use
    • 1.2.5. Estimates and forecasts timeline
  • 1.3. Research Methodology
  • 1.4. Information Procurement
    • 1.4.1. Purchased database
    • 1.4.2. GVR's internal database
    • 1.4.3. Secondary sources
    • 1.4.4. Primary research
    • 1.4.5. Details of primary research
      • 1.4.5.1. Data for primary interviews in North America
      • 1.4.5.2. Data for primary interviews in Europe
      • 1.4.5.3. Data for primary interviews in Asia Pacific
      • 1.4.5.4. Data for primary interviews in Latin America
      • 1.4.5.5. Data for Primary interviews in MEA
  • 1.5. Information or Data Analysis
    • 1.5.1. Data analysis models
  • 1.6. Market Formulation & Validation
  • 1.7. Model Details
    • 1.7.1. Commodity flow analysis (Model 1)
    • 1.7.2. Approach 1: Commodity flow approach
    • 1.7.3. Volume price analysis (Model 2)
    • 1.7.4. Approach 2: Volume price analysis
  • 1.8. List of Secondary Sources
  • 1.9. List of Primary Sources
  • 1.10. Objectives

Chapter 2. Executive Summary

  • 2.1. Market Outlook
  • 2.2. Segment Outlook
    • 2.2.1. Modality outlook
    • 2.2.2. Therapeutic area outlook
    • 2.2.3. Services outlook
    • 2.2.4. End Use outlook
  • 2.3. Regional outlook
  • 2.4. Competitive Insights

Chapter 3. Clinical Trial Imaging Market Variables, Trends & Scope

  • 3.1. Market Lineage Outlook
    • 3.1.1. Parent Market Outlook
    • 3.1.2. Related/ancillary market outlook
  • 3.2. Market Dynamics
    • 3.2.1. Market Driver Analysis
      • 3.2.1.1. Growing number of pharmaceutical and biotechnological companies
      • 3.2.1.2. Growing number of contract research organization (CRO)
      • 3.2.1.3. Increasing research and development investments
    • 3.2.2. Market Restraint Analysis
      • 3.2.2.1. High cost of machineries and installations
  • 3.3. Clinical Trial Imaging Market Analysis Tools
    • 3.3.1. Industry Analysis - Porter's
      • 3.3.1.1. Bargaining power of suppliers
      • 3.3.1.2. Bargaining power of buyers
      • 3.3.1.3. Threat of substitutes
      • 3.3.1.4. Threat of new entrants
      • 3.3.1.5. Competitive rivalry
    • 3.3.2. PESTEL Analysis
      • 3.3.2.1. Political landscape
      • 3.3.2.2. Economic landscape
      • 3.3.2.3. Social landscape
      • 3.3.2.4. Technological landscape
      • 3.3.2.5. Environmental landscape
      • 3.3.2.6. Legal landscape

Chapter 4. Clinical Trial Imaging Market: Modality Estimates & Trend Analysis

  • 4.1. Segment Dashboard
  • 4.2. Clinical Trial Imaging Market: Modality Movement Analysis
  • 4.3. Clinical Trial Imaging Market by Modality Outlook (USD Million)
  • 4.4. Market Size & Forecasts and Trend Analyses, 2018 to 2030 for the following
  • 4.5. Computed Tomography Scan
    • 4.5.1. Computed Tomography Scan Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 4.6. Magnetic Resonance Imaging
    • 4.6.1. Magnetic Resonance Imaging Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 4.7. X-Ray
    • 4.7.1. X-Ray Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 4.8. Ultrasound
    • 4.8.1. Ultrasound Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 4.9. Optical Coherence Tomography (OCT)
    • 4.9.1. Optical Coherence Tomography (OCT) Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 4.10. Other Modalities
    • 4.10.1. Other Modalities Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)

Chapter 5. Clinical Trial Imaging Market: Therapeutic Area Estimates & Trend Analysis

  • 5.1. Segment Dashboard
  • 5.2. Clinical Trial Imaging Market: Therapeutic Area Movement Analysis
  • 5.3. Clinical Trial Imaging Market by Therapeutic Area Outlook (USD Million)
  • 5.4. Market Size & Forecasts and Trend Analyses, 2018 to 2030 for the following
  • 5.5. Neurovascular Diseases
    • 5.5.1. Neurovascular Diseases Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 5.6. Cardiovascular Diseases
    • 5.6.1. Cardiovascular Diseases Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 5.7. Orthopedics & MSK Disorders
    • 5.7.1. Orthopedics & MSK Disorders Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 5.8. Oncology
    • 5.8.1. Oncology Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 5.9. Ophthalmology
    • 5.9.1. Ophthalmology Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 5.10. Nephrology
    • 5.10.1. Nephrology Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 5.11. Other Therapeutic Areas
    • 5.11.1. Other Therapeutic Areas Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)

Chapter 6. Clinical Trial Imaging Market: Services Estimates & Trend Analysis

  • 6.1. Segment Dashboard
  • 6.2. Clinical Trial Imaging Market: Services Movement Analysis
  • 6.3. Clinical Trial Imaging Market by Services Outlook (USD Million)
  • 6.4. Market Size & Forecasts and Trend Analyses, 2018 to 2030 for the following
  • 6.5. Clinical Trial Design and Consultation Services
    • 6.5.1. Clinical Trial Design and Consultation Services Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 6.6. Reading and Analytical Services
    • 6.6.1. Reading and Analytical Services Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 6.7. Operational Imaging Services
    • 6.7.1. Operational Imaging Services Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 6.8. System and Technology Support Services
    • 6.8.1. System and Technology Support Services Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 6.9. Project and Data Management
    • 6.9.1. Project and Data Management Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)

Chapter 7. Clinical Trial Imaging Market: End Use Estimates & Trend Analysis

  • 7.1. Segment Dashboard
  • 7.2. Clinical Trial Imaging Market: End Use Movement Analysis
  • 7.3. Clinical Trial Imaging Market by End Use Outlook (USD Million)
  • 7.4. Market Size & Forecasts and Trend Analyses, 2018 to 2030 for the following
  • 7.5. Biotechnology and Pharmaceutical Companies
    • 7.5.1. Biotechnology and Pharmaceutical Companies Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 7.6. Medical Devices Manufacturers
    • 7.6.1. Medical Devices Manufacturers Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 7.7. Academic and Government Research Institutes
    • 7.7.1. Academic and Government Research Institutes Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 7.8. Contract Research Organizations (CROs)
    • 7.8.1. Contract Research Organizations (CROs) Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 7.9. Other End Users
    • 7.9.1. Other End Users Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)

Chapter 8. Clinical Trial Imaging Market: Regional Estimates & Trend Analysis

  • 8.1. Regional Market Share Analysis, 2024 & 2030
  • 8.2. Regional Market Dashboard
  • 8.3. Global Regional Market Snapshot
  • 8.4. Market Size, & Forecasts Trend Analysis, 2018 to 2030:
  • 8.5. North America
    • 8.5.1. U.S.
      • 8.5.1.1. Key country dynamics
      • 8.5.8.2. Regulatory framework/ reimbursement structure
      • 8.5.1.3. Competitive scenario
      • 8.5.1.4. U.S. market estimates and forecasts 2018 to 2030 (USD Million)
    • 8.5.2. Canada
      • 8.5.2.1. Key country dynamics
      • 8.5.2.2. Regulatory framework/ reimbursement structure
      • 8.5.2.3. Competitive scenario
      • 8.5.2.4. Canada market estimates and forecasts 2018 to 2030 (USD Million)
    • 8.5.3. Mexico
      • 8.5.3.1. Key country dynamics
      • 8.5.3.2. Regulatory framework/ reimbursement structure
      • 8.5.3.3. Competitive scenario
      • 8.5.3.4. Mexico market estimates and forecasts 2018 to 2030 (USD Million)
  • 8.6. Europe
    • 8.6.1. UK
      • 8.6.1.1. Key country dynamics
      • 8.6.1.2. Regulatory framework/ reimbursement structure
      • 8.6.1.3. Competitive scenario
      • 8.6.8.4. UK market estimates and forecasts 2018 to 2030 (USD Million)
    • 8.6.2. Germany
      • 8.6.2.1. Key country dynamics
      • 8.6.2.2. Regulatory framework/ reimbursement structure
      • 8.6.2.3. Competitive scenario
      • 8.6.2.4. Germany market estimates and forecasts 2018 to 2030 (USD Million)
    • 8.6.3. France
      • 8.6.3.1. Key country dynamics
      • 8.6.3.2. Regulatory framework/ reimbursement structure
      • 8.6.3.3. Competitive scenario
      • 8.6.3.4. France market estimates and forecasts 2018 to 2030 (USD Million)
    • 8.6.4. Italy
      • 8.6.4.1. Key country dynamics
      • 8.6.4.2. Regulatory framework/ reimbursement structure
      • 8.6.4.3. Competitive scenario
      • 8.6.4.4. Italy market estimates and forecasts 2018 to 2030 (USD Million)
    • 8.6.5. Spain
      • 8.6.5.1. Key country dynamics
      • 8.6.5.2. Regulatory framework/ reimbursement structure
      • 8.6.5.3. Competitive scenario
      • 8.6.5.4. Spain market estimates and forecasts 2018 to 2030 (USD Million)
    • 8.6.6. Norway
      • 8.6.6.1. Key country dynamics
      • 8.6.6.2. Regulatory framework/ reimbursement structure
      • 8.6.6.3. Competitive scenario
      • 8.6.6.4. Norway market estimates and forecasts 2018 to 2030 (USD Million)
    • 8.6.7. Sweden
      • 8.6.7.1. Key country dynamics
      • 8.6.7.2. Regulatory framework/ reimbursement structure
      • 8.6.7.3. Competitive scenario
      • 8.6.7.4. Sweden market estimates and forecasts 2018 to 2030 (USD Million)
    • 8.6.8. Denmark
      • 8.6.8.1. Key country dynamics
      • 8.6.8.2. Regulatory framework/ reimbursement structure
      • 8.6.8.3. Competitive scenario
      • 8.6.8.4. Denmark market estimates and forecasts 2018 to 2030 (USD Million)
  • 8.7. Asia Pacific
    • 8.7.8. Japan
      • 8.7.1.1. Key country dynamics
      • 8.7.1.2. Regulatory framework/ reimbursement structure
      • 8.7.1.3. Competitive scenario
      • 8.7.1.4. Japan market estimates and forecasts 2018 to 2030 (USD Million)
    • 8.7.2. China
      • 8.7.2.1. Key country dynamics
      • 8.7.2.2. Regulatory framework/ reimbursement structure
      • 8.7.2.3. Competitive scenario
      • 8.7.2.4. China market estimates and forecasts 2018 to 2030 (USD Million)
    • 8.7.3. India
      • 8.7.3.1. Key country dynamics
      • 8.7.3.2. Regulatory framework/ reimbursement structure
      • 8.7.3.3. Competitive scenario
      • 8.7.3.4. India market estimates and forecasts 2018 to 2030 (USD Million)
    • 8.7.4. Australia
      • 8.7.4.1. Key country dynamics
      • 8.7.4.2. Regulatory framework/ reimbursement structure
      • 8.7.4.3. Competitive scenario
      • 8.7.4.4. Australia market estimates and forecasts 2018 to 2030 (USD Million)
    • 8.7.5. South Korea
      • 8.7.5.1. Key country dynamics
      • 8.7.5.2. Regulatory framework/ reimbursement structure
      • 8.7.5.3. Competitive scenario
      • 8.7.5.4. South Korea market estimates and forecasts 2018 to 2030 (USD Million)
    • 8.7.6. Thailand
      • 8.7.6.1. Key country dynamics
      • 8.7.6.2. Regulatory framework/ reimbursement structure
      • 8.7.6.3. Competitive scenario
      • 8.7.6.4. Thailand market estimates and forecasts 2018 to 2030 (USD Million)
  • 8.8. Latin America
    • 8.8.1. Brazil
      • 8.8.1.1. Key country dynamics
      • 8.8.1.2. Regulatory framework/ reimbursement structure
      • 8.8.1.3. Competitive scenario
      • 8.8.1.4. Brazil market estimates and forecasts 2018 to 2030 (USD Million)
    • 8.8.2. Argentina
      • 8.8.2.1. Key country dynamics
      • 8.8.2.2. Regulatory framework/ reimbursement structure
      • 8.8.2.3. Competitive scenario
      • 8.8.2.4. Argentina market estimates and forecasts 2018 to 2030 (USD Million)
  • 8.9. Middle East & Africa
    • 8.9.1. South Africa
      • 8.9.1.1. Key country dynamics
      • 8.9.1.2. Regulatory framework/ reimbursement structure
      • 8.9.1.3. Competitive scenario
      • 8.9.1.4. South Africa market estimates and forecasts 2018 to 2030 (USD Million)
    • 8.9.2. Saudi Arabia
      • 8.9.2.1. Key country dynamics
      • 8.9.2.2. Regulatory framework/ reimbursement structure
      • 8.9.2.3. Competitive scenario
      • 8.9.2.4. Saudi Arabia market estimates and forecasts 2018 to 2030 (USD Million)
    • 8.9.3. UAE
      • 8.9.3.1. Key country dynamics
      • 8.9.3.2. Regulatory framework/ reimbursement structure
      • 8.9.3.3. Competitive scenario
      • 8.9.3.4. UAE market estimates and forecasts 2018 to 2030 (USD Million)
    • 8.9.4. Kuwait
      • 8.9.4.1. Key country dynamics
      • 8.9.4.2. Regulatory framework/ reimbursement structure
      • 8.9.4.3. Competitive scenario
      • 8.9.4.4. Kuwait market estimates and forecasts 2018 to 2030 (USD Million)

Chapter 9. Competitive Landscape

  • 9.1. Recent Developments & Impact Analysis, By Key Market Participants
    • 9.1.1 Company/Competition Categorization
    • 9.1.2. Innovators
  • 9.2. Vendor Landscape
    • 9.2.1. List of key distributors and channel partners
    • 9.2.2. Key customers
    • 9.2.3. Key company market share analysis, 2024
    • 9.2.4. IXICO plc
      • 9.2.4.1. Company overview
      • 9.2.4.2. Financial performance
      • 9.2.4.3. Product benchmarking
      • 9.2.4.4. Strategic initiatives
    • 9.2.5. Navitas Life Sciences
      • 9.2.5.1. Company overview
      • 9.2.5.2. Financial performance
      • 9.2.5.3. Product benchmarking
      • 9.2.5.4. Strategic initiatives
    • 9.2.6. Resonance Health
      • 9.2.6.1. Company overview
      • 9.2.6.2. Financial performance
      • 9.2.6.3. Product benchmarking
      • 9.2.6.4. Strategic initiatives
    • 9.2.7. ProScan Imaging
      • 9.2.7.1. Company overview
      • 9.2.7.2. Financial performance
      • 9.2.7.3. Product benchmarking
      • 9.2.7.4. Strategic initiatives
    • 9.2.8. Radiant Sage LLC
      • 9.2.8.1. Company overview
      • 9.2.8.2. Financial performance
      • 9.2.8.3. Product benchmarking
      • 9.2.8.4. Strategic initiatives
    • 9.2.9. Medpace
      • 9.2.9.1. Company overview
      • 9.2.9.2. Financial performance
      • 9.2.9.3. Product benchmarking
      • 9.2.9.4. Strategic initiatives
    • 9.2.10. Biomedical Systems Corp.
      • 9.2.10.1. Company overview
      • 9.2.10.2. Financial performance
      • 9.2.10.3. Product benchmarking
      • 9.2.10.4. Strategic initiatives
    • 9.2.11. Cardiovascular Imaging Technologies
      • 9.2.11.1. Company overview
      • 9.2.11.2. Financial performance
      • 9.2.11.3. Product benchmarking
      • 9.2.11.4. Strategic initiatives
    • 9.2.12. Intrinsic Imaging
      • 9.2.12.1. Company overview
      • 9.2.12.2. Financial performance
      • 9.2.12.3. Product benchmarking
      • 9.2.12.4. Strategic initiatives
    • 9.2.13. BioTelemetry
      • 9.2.13.1. Company overview
      • 9.2.13.2. Financial performance
      • 9.2.13.3. Product benchmarking
      • 9.2.13.4. Strategic initiatives

List of Tables

  • Table 1 List of Abbreviation
  • Table 2 North America clinical trial imaging market, by region, 2018 - 2030 (USD Million)
  • Table 3 North America clinical trial imaging market, by modality, 2018 - 2030 (USD Million)
  • Table 4 North America clinical trial imaging market, by therapeutic area, 2018 - 2030 (USD Million)
  • Table 5 North America clinical trial imaging market, by services, 2018 - 2030 (USD Million)
  • Table 6 North America clinical trial imaging market, by end use, 2018 - 2030 (USD Million)
  • Table 7 U.S. clinical trial imaging market, by modality, 2018 - 2030 (USD Million)
  • Table 8 U.S. clinical trial imaging market, by therapeutic area, 2018 - 2030 (USD Million)
  • Table 9 U.S. clinical trial imaging market, by services, 2018 - 2030 (USD Million)
  • Table 10 U.S. clinical trial imaging market, by end use, 2018 - 2030 (USD Million)
  • Table 11 Canada clinical trial imaging market, by modality, 2018 - 2030 (USD Million)
  • Table 12 Canada clinical trial imaging market, by therapeutic area, 2018 - 2030 (USD Million)
  • Table 13 Canada clinical trial imaging market, by services, 2018 - 2030 (USD Million)
  • Table 14 Canada clinical trial imaging market, by end use, 2018 - 2030 (USD Million)
  • Table 15 Mexico clinical trial imaging market, by modality, 2018 - 2030 (USD Million)
  • Table 16 Mexico clinical trial imaging market, by therapeutic area, 2018 - 2030 (USD Million)
  • Table 17 Mexico clinical trial imaging market, by services, 2018 - 2030 (USD Million)
  • Table 18 Mexico clinical trial imaging market, by end use, 2018 - 2030 (USD Million)
  • Table 19 Europe clinical trial imaging market, by region, 2018 - 2030 (USD Million)
  • Table 20 Europe clinical trial imaging market, by modality, 2018 - 2030 (USD Million)
  • Table 21 Europe clinical trial imaging market, by therapeutic area, 2018 - 2030 (USD Million)
  • Table 22 Europe clinical trial imaging market, by services, 2018 - 2030 (USD Million)
  • Table 23 Europe clinical trial imaging market, by end use, 2018 - 2030 (USD Million)
  • Table 24 Germany clinical trial imaging market, by modality, 2018 - 2030 (USD Million)
  • Table 25 Germany clinical trial imaging market, by therapeutic area, 2018 - 2030 (USD Million)
  • Table 26 Germany clinical trial imaging market, by services, 2018 - 2030 (USD Million)
  • Table 27 Germany clinical trial imaging market, by end use, 2018 - 2030 (USD Million)
  • Table 28 UK clinical trial imaging market, by modality, 2018 - 2030 (USD Million)
  • Table 29 UK clinical trial imaging market, by therapeutic area, 2018 - 2030 (USD Million)
  • Table 30 UK clinical trial imaging market, by services, 2018 - 2030 (USD Million)
  • Table 31 UK clinical trial imaging market, by end use, 2018 - 2030 (USD Million)
  • Table 32 France clinical trial imaging market, by modality, 2018 - 2030 (USD Million)
  • Table 33 France clinical trial imaging market, by therapeutic area, 2018 - 2030 (USD Million)
  • Table 34 France clinical trial imaging market, by services, 2018 - 2030 (USD Million)
  • Table 35 France clinical trial imaging market, by end use, 2018 - 2030 (USD Million)
  • Table 36 Italy clinical trial imaging market, by modality, 2018 - 2030 (USD Million)
  • Table 37 Italy clinical trial imaging market, by therapeutic area, 2018 - 2030 (USD Million)
  • Table 38 Italy clinical trial imaging market, by services, 2018 - 2030 (USD Million)
  • Table 39 Italy clinical trial imaging market, by end use, 2018 - 2030 (USD Million)
  • Table 40 Spain clinical trial imaging market, by modality, 2018 - 2030 (USD Million)
  • Table 41 Spain clinical trial imaging market, by therapeutic area, 2018 - 2030 (USD Million)
  • Table 42 Spain clinical trial imaging market, by services, 2018 - 2030 (USD Million)
  • Table 43 Spain clinical trial imaging market, by end use, 2018 - 2030 (USD Million)
  • Table 44 Sweden clinical trial imaging market, by modality, 2018 - 2030 (USD Million)
  • Table 45 Sweden clinical trial imaging market, by therapeutic area, 2018 - 2030 (USD Million)
  • Table 46 Sweden clinical trial imaging market, by services, 2018 - 2030 (USD Million)
  • Table 47 Sweden clinical trial imaging market, by end use, 2018 - 2030 (USD Million)
  • Table 48 Denmark clinical trial imaging market, by modality, 2018 - 2030 (USD Million)
  • Table 49 Denmark clinical trial imaging market, by therapeutic area, 2018 - 2030 (USD Million)
  • Table 50 Denmark clinical trial imaging market, by services, 2018 - 2030 (USD Million)
  • Table 51 Denmark clinical trial imaging market, by end use, 2018 - 2030 (USD Million)
  • Table 52 Norway clinical trial imaging market, by modality, 2018 - 2030 (USD Million)
  • Table 53 Norway clinical trial imaging market, by therapeutic area, 2018 - 2030 (USD Million)
  • Table 54 Norway clinical trial imaging market, by services, 2018 - 2030 (USD Million)
  • Table 55 Norway clinical trial imaging market, by end use, 2018 - 2030 (USD Million)
  • Table 56 Asia Pacific clinical trial imaging market, by region, 2018 - 2030 (USD Million)
  • Table 57 Asia Pacific clinical trial imaging market, by modality, 2018 - 2030 (USD Million)
  • Table 58 Asia Pacific clinical trial imaging market, by therapeutic area, 2018 - 2030 (USD Million)
  • Table 59 Asia Pacific clinical trial imaging market, by services, 2018 - 2030 (USD Million)
  • Table 60 Asia Pacific clinical trial imaging market, by end use, 2018 - 2030 (USD Million)
  • Table 61 China clinical trial imaging market, by modality, 2018 - 2030 (USD Million)
  • Table 62 China clinical trial imaging market, by therapeutic area, 2018 - 2030 (USD Million)
  • Table 63 China clinical trial imaging market, by services, 2018 - 2030 (USD Million)
  • Table 64 China clinical trial imaging market, by end use, 2018 - 2030 (USD Million)
  • Table 65 Japan clinical trial imaging market, by modality, 2018 - 2030 (USD Million)
  • Table 66 Japan clinical trial imaging market, by therapeutic area, 2018 - 2030 (USD Million)
  • Table 67 Japan clinical trial imaging market, by services, 2018 - 2030 (USD Million)
  • Table 68 Japan clinical trial imaging market, by end use, 2018 - 2030 (USD Million)
  • Table 69 India clinical trial imaging market, by modality, 2018 - 2030 (USD Million)
  • Table 70 India clinical trial imaging market, by therapeutic area, 2018 - 2030 (USD Million)
  • Table 71 India clinical trial imaging market, by services, 2018 - 2030 (USD Million)
  • Table 72 India clinical trial imaging market, by end use, 2018 - 2030 (USD Million)
  • Table 73 Australia clinical trial imaging market, by modality, 2018 - 2030 (USD Million)
  • Table 74 Australia clinical trial imaging market, by therapeutic area, 2018 - 2030 (USD Million)
  • Table 75 Australia clinical trial imaging market, by services, 2018 - 2030 (USD Million)
  • Table 76 Australia clinical trial imaging market, by end use, 2018 - 2030 (USD Million)
  • Table 77 South Korea clinical trial imaging market, by modality, 2018 - 2030 (USD Million)
  • Table 78 South Korea clinical trial imaging market, by therapeutic area, 2018 - 2030 (USD Million)
  • Table 79 South Korea clinical trial imaging market, by services, 2018 - 2030 (USD Million)
  • Table 80 South Korea clinical trial imaging market, by end use, 2018 - 2030 (USD Million)
  • Table 81 Thailand clinical trial imaging market, by modality, 2018 - 2030 (USD Million)
  • Table 82 Thailand clinical trial imaging market, by therapeutic area, 2018 - 2030 (USD Million)
  • Table 83 Thailand clinical trial imaging market, by services, 2018 - 2030 (USD Million)
  • Table 84 Thailand clinical trial imaging market, by end use, 2018 - 2030 (USD Million)
  • Table 85 Latin America clinical trial imaging market, by region, 2018 - 2030 (USD Million)
  • Table 86 Latin America clinical trial imaging market, by modality, 2018 - 2030 (USD Million)
  • Table 87 Latin America clinical trial imaging market, by therapeutic area, 2018 - 2030 (USD Million)
  • Table 88 Latin America clinical trial imaging market, by services, 2018 - 2030 (USD Million)
  • Table 89 Latin America clinical trial imaging market, by end use, 2018 - 2030 (USD Million)
  • Table 90 Brazil clinical trial imaging market, by modality, 2018 - 2030 (USD Million)
  • Table 91 Brazil clinical trial imaging market, by therapeutic area, 2018 - 2030 (USD Million)
  • Table 92 Brazil clinical trial imaging market, by services, 2018 - 2030 (USD Million)
  • Table 93 Brazil clinical trial imaging market, by end use, 2018 - 2030 (USD Million)
  • Table 94 Argentina clinical trial imaging market, by modality, 2018 - 2030 (USD Million)
  • Table 95 Argentina clinical trial imaging market, by therapeutic area, 2018 - 2030 (USD Million)
  • Table 96 Argentina clinical trial imaging market, by services, 2018 - 2030 (USD Million)
  • Table 97 Argentina clinical trial imaging market, by end use, 2018 - 2030 (USD Million)
  • Table 98 Middle East and Africa clinical trial imaging market, by region, 2018 - 2030 (USD Million)
  • Table 99 Middle East and Africa clinical trial imaging market, by modality, 2018 - 2030 (USD Million)
  • Table 100 Middle East and Africa clinical trial imaging market, by therapeutic area, 2018 - 2030 (USD Million)
  • Table 101 Middle East and Africa clinical trial imaging market, by services, 2018 - 2030 (USD Million)
  • Table 102 Middle East and Africa clinical trial imaging market, by end use, 2018 - 2030 (USD Million)
  • Table 103 South Africa clinical trial imaging market, by modality, 2018 - 2030 (USD Million)
  • Table 104 South Africa clinical trial imaging market, by therapeutic area, 2018 - 2030 (USD Million)
  • Table 105 South Africa clinical trial imaging market, by services, 2018 - 2030 (USD Million)
  • Table 106 South Africa clinical trial imaging market, by end use, 2018 - 2030 (USD Million)
  • Table 107 Saudi Arabia clinical trial imaging market, by modality, 2018 - 2030 (USD Million)
  • Table 108 Saudi Arabia clinical trial imaging market, by therapeutic area, 2018 - 2030 (USD Million)
  • Table 109 Saudi Arabia clinical trial imaging market, by services, 2018 - 2030 (USD Million)
  • Table 110 Saudi Arabia clinical trial imaging market, by end use, 2018 - 2030 (USD Million)
  • Table 111 UAE clinical trial imaging market, by modality, 2018 - 2030 (USD Million)
  • Table 112 UAE clinical trial imaging market, by therapeutic area, 2018 - 2030 (USD Million)
  • Table 113 UAE clinical trial imaging market, by services, 2018 - 2030 (USD Million)
  • Table 114 UAE clinical trial imaging market, by end use, 2018 - 2030 (USD Million)
  • Table 115 Kuwait clinical trial imaging market, by modality, 2018 - 2030 (USD Million)
  • Table 116 Kuwait clinical trial imaging market, by therapeutic area, 2018 - 2030 (USD Million)
  • Table 117 Kuwait clinical trial imaging market, by services, 2018 - 2030 (USD Million)
  • Table 118 Kuwait clinical trial imaging market, by end use, 2018 - 2030 (USD Million)

List of Figures

  • Fig. 1 Market research process
  • Fig. 2 Data triangulation techniques
  • Fig. 3 Primary research pattern
  • Fig. 4 Primary interviews in North America
  • Fig. 5 Primary interviews in Europe
  • Fig. 6 Primary interviews in APAC
  • Fig. 7 Primary interviews in Latin America
  • Fig. 8 Primary interviews in MEA
  • Fig. 9 Market research approaches
  • Fig. 10 Value-chain-based sizing & forecasting
  • Fig. 11 QFD modeling for market share assessment
  • Fig. 12 Market formulation & validation
  • Fig. 13 clinical trial imaging market: market outlook
  • Fig. 14 clinical trial imaging market competitive insights
  • Fig. 15 Parent market outlook
  • Fig. 16 Related/ancillary market outlook
  • Fig. 17 Penetration and growth prospect mapping
  • Fig. 18 Industry value chain analysis
  • Fig. 19 Clinical trial imaging market driver impact
  • Fig. 20 Clinical trial imaging market restraint impact
  • Fig. 21 Clinical trial imaging market strategic initiatives analysis
  • Fig. 22 Clinical trial imaging market: Modality movement analysis
  • Fig. 23 Clinical trial imaging market: Modality outlook and key takeaways
  • Fig. 24 Computed tomography scan market estimates and forecast, 2018 - 2030
  • Fig. 25 Magnetic resonance imaging market estimates and forecast, 2018 - 2030
  • Fig. 26 X-Ray market estimates and forecast, 2018 - 2030
  • Fig. 27 Ultrasound market estimates and forecast, 2018 - 2030
  • Fig. 28 Optical coherence tomography (OCT) market estimates and forecast, 2018 - 2030
  • Fig. 29 Other modalities market estimates and forecast, 2018 - 2030
  • Fig. 30 Clinical trial imaging market: Therapeutic area movement analysis
  • Fig. 31 Clinical trial imaging market: Therapeutic area outlook and key takeaways
  • Fig. 32 Neurovascular diseases market estimates and forecast, 2018 - 2030
  • Fig. 33 Cardiovascular diseases market estimates and forecast, 2018 - 2030
  • Fig. 34 Oncology market estimates and forecast, 2018 - 2030
  • Fig. 35 Ophthalmology market estimates and forecast, 2018 - 2030
  • Fig. 36 Nephrology market estimates and forecast, 2018 - 2030
  • Fig. 37 Other therapeutic areas market estimates and forecast, 2018 - 2030
  • Fig. 38 Clinical trial imaging market: Services movement analysis
  • Fig. 39 Clinical trial imaging market: Services outlook and key takeaways
  • Fig. 40 Clinical trial design and consultation services market estimates and forecast, 2018 - 2030
  • Fig. 41 Reading and analytical services market estimates and forecast, 2018 - 2030
  • Fig. 42 Operational imaging services market estimates and forecast, 2018 - 2030
  • Fig. 43 System and technology support services market estimates and forecast, 2018 - 2030
  • Fig. 44 Project and data management market estimates and forecast, 2018 - 2030
  • Fig. 45 Clinical trial imaging market: End use movement analysis
  • Fig. 46 Clinical trial imaging market: End use outlook and key takeaways
  • Fig. 47 Biotechnology companies market estimates and forecast, 2018 - 2030
  • Fig. 48 Medical devices manufacturers market estimates and forecast, 2018 - 2030
  • Fig. 49 Academic and government research institutes market estimates and forecast, 2018 - 2030
  • Fig. 50 Contract research organizations (CROs) market estimates and forecast, 2018 - 2030
  • Fig. 51 Other end users market estimates and forecast, 2018 - 2030
  • Fig. 52 Global clinical trial imaging market: Regional movement analysis
  • Fig. 53 Global clinical trial imaging market: Regional outlook and key takeaways
  • Fig. 54 Global market shares and leading players
  • Fig. 55 North America market share and leading players
  • Fig. 56 Europe market share and leading players
  • Fig. 57 Asia Pacific market share and leading players
  • Fig. 58 Latin America market share and leading players
  • Fig. 59 Middle East & Africa market share and leading players
  • Fig. 60 North America
  • Fig. 61 North America market estimates and forecast, 2018 - 2030
  • Fig. 62 U.S.
  • Fig. 63 U.S. market estimates and forecast, 2018 - 2030
  • Fig. 64 Canada
  • Fig. 65 Canada market estimates and forecast, 2018 - 2030
  • Fig. 66 Mexico
  • Fig. 67 Mexico market estimates and forecast, 2018 - 2030
  • Fig. 68 Europe
  • Fig. 69 Europe. market estimates and forecast, 2018 - 2030
  • Fig. 70 UK
  • Fig. 71 UK market estimates and forecast, 2018 - 2030
  • Fig. 72 Germany
  • Fig. 73 Germany market estimates and forecast, 2018 - 2030
  • Fig. 74 France
  • Fig. 75 France market estimates and forecast, 2018 - 2030
  • Fig. 76 Italy
  • Fig. 77 Italy market estimates and forecast, 2018 - 2030
  • Fig. 78 Spain
  • Fig. 79 Spain market estimates and forecast, 2018 - 2030
  • Fig. 80 Sweden
  • Fig. 81 Sweden market estimates and forecast, 2018 - 2030
  • Fig. 82 Denmark
  • Fig. 83 Denmark market estimates and forecast, 2018 - 2030
  • Fig. 84 Norway
  • Fig. 85 Norway market estimates and forecast, 2018 - 2030
  • Fig. 86 Asia Pacific
  • Fig. 87 Asia Pacific market estimates and forecast, 2018 - 2030
  • Fig. 88 China
  • Fig. 89 China market estimates and forecast, 2018 - 2030
  • Fig. 90 Japan
  • Fig. 91 Japan market estimates and forecast, 2018 - 2030
  • Fig. 92 India
  • Fig. 93 India market estimates and forecast, 2018 - 2030
  • Fig. 94 Australia
  • Fig. 95 Australia market estimates and forecast, 2018 - 2030
  • Fig. 96 South Korea
  • Fig. 97 South Korea market estimates and forecast, 2018 - 2030
  • Fig. 98 Thailand
  • Fig. 99 Thailand market estimates and forecast, 2018 - 2030
  • Fig. 100 Latin America
  • Fig. 101 Latin America market estimates and forecast, 2018 - 2030
  • Fig. 102 Brazil
  • Fig. 103 Brazil market estimates and forecast, 2018 - 2030
  • Fig. 104 Argentina
  • Fig. 105 Argentina market estimates and forecast, 2018 - 2030
  • Fig. 106 Middle East and Africa
  • Fig. 107 Middle East and Africa. market estimates and forecast, 2018 - 2030
  • Fig. 108 Saudi Arabia
  • Fig. 109 Saudi Arabia market estimates and forecast, 2018 - 2030
  • Fig. 110 South Africa
  • Fig. 111 South Africa market estimates and forecast, 2018 - 2030
  • Fig. 112 UAE
  • Fig. 113 UAE market estimates and forecast, 2018 - 2030
  • Fig. 114 Kuwait
  • Fig. 115 Kuwait market estimates and forecast, 2018 - 2030
  • Fig. 116 Participant categorization- Clinical trial imaging market
  • Fig. 117 Market share of key market players- Clinical trial imaging market